Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chlorpropamide pharmaceutical composition and medical application thereof

A technology of chlorpropamide and its composition, which is applied in the field of chlorpropamide pharmaceutical composition, can solve problems such as no related reports on chlorpropamide cardiomyopathy, and achieve outstanding substantive features, significant progress, and effects strong effect

Inactive Publication Date: 2016-08-17
周飞燕
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] So far, there has been no report on the correlation between chlorpropamide and its pharmaceutical composition and diabetic cardiomyopathy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chlorpropamide pharmaceutical composition and medical application thereof
  • Chlorpropamide pharmaceutical composition and medical application thereof
  • Chlorpropamide pharmaceutical composition and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1: Compound (I) Separation Preparation and Structure Confirmation

[0021] Sources of reagents: ethanol, petroleum ether, ethyl acetate, n-butanol, and dichloromethane were of analytical grade, purchased from Shanghai Lingfeng Chemical Reagent Co., Ltd. Methanol, of analytical grade, were purchased from Jiangsu Hanbang Chemical Reagent Co., Ltd.

[0022] Separation method: (a) Grind the dry root tuber (2kg) of Morinda officinalis, extract with 80% ethanol under heat reflux (15L×3 times), combine the extracts, concentrate until no alcohol smell (3L), and then use petroleum ether ( 3L×3 times), ethyl acetate (3L×3 times) and water-saturated n-butanol (3L×3 times) were extracted to obtain petroleum ether extract, ethyl acetate extract and n-butanol extract respectively; (b ) The n-butanol extract in step (a) is removed with D101 type macroporous resin, first elutes 8 column volumes with 10% ethanol, then elutes 10 column volumes with 70% ethanol, collects 70% eluat...

Embodiment 2

[0025] Embodiment 2: pharmacological action

[0026] 1. Materials and methods

[0027] 1.1 Animals

[0028] 40 Wistar rats aged 3 to 4 months, half male and half male, weighing 210 g to 250 g, were provided by the Experimental Animal Center of Jiamusi University. The animals were kept in a ventilated and dry environment with a temperature of (22±1)°C, a relative humidity of 55%-65%, and a 12-h light cycle, and were fed with maintenance diet 1022 for rats and mice.

[0029] 1.2 Reagents and samples

[0030] Chlorpropamide was purchased from China National Institutes for Food and Drug Control. Compound (I) is self-made, and the preparation method is shown in Example 1. Streptozotocin (STZ) was purchased from Sigma Company of the United States; SOD, Coomassie Brilliant Blue protein assay kits were purchased from Nanjing Jiancheng Bioengineering Institute. Triglyceride kit was purchased from Changchun Huili Engineering Technology Development Center.

[0031] 1.3 Instruments ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition of chlorpropamide and its medical application. The pharmaceutical composition of chlorpropamide provided by the invention contains chlorpropamide and a kind of The novel natural product compound (Ⅰ), chlorpropamide, compound (Ⅰ) can protect the activity of antioxidant enzymes in rats, scavenge free radicals, and inhibit lipid peroxidation, suggesting that antioxidants are chlorpropamide, One of the mechanisms by which compound (I) protects the kidneys of DM rats. After the combined use of chlorpropamide and compound (I), the blood lipid regulation effect and renal protection effect on rats with type 2 diabetes were further improved. Early application can effectively delay the occurrence and development of diabetic nephropathy, and can be developed into a treatment for diabetic nephropathy. The drug for pathological changes has outstanding substantive features and significant progress compared with the prior art.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a new application of chlorpropamide, in particular to a pharmaceutical composition of chlorpropamide and its medical application. Background technique [0002] The indication of chlorpropamide is suitable for mild and moderate type Ⅱ diabetes mellitus whose curative effect is not satisfied with diet alone. The patient's islet β cells have a certain function of secreting insulin, and there is no serious complication. This product can also be used for central diabetes insipidus. [0003] So far, there is no report on the correlation between chlorpropamide and its pharmaceutical composition and diabetic cardiomyopathy. Contents of the invention [0004] The object of the present invention is to provide a pharmaceutical composition of chlorpropamide, which contains chlorpropamide and a natural product, and the chlorpropamide and the natural product can synergistically treat diabetic nephro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D493/20A61K31/64A61K31/357A61P13/12A61P3/10
CPCC07D493/20A61K31/357A61K31/64
Inventor 周飞燕
Owner 周飞燕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com